United Services Automobile Association Corcept Therapeutics Inc Transaction History

United Services Automobile Association

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$49.85 - $114.22 $302,539 - $693,201	6,069 New	6,069 $693,000
Q2 2022 Aug 16, 2022	BUY	$17.33 - $25.3 $176,748 - $258,034	10,199 New	10,199 $242,000
Q3 2019 Nov 13, 2019	SELL	$10.41 - $14.66 $550,335 - $775,015	-52,866 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$11.29 - $17.19 $1,411 - $2,148	125 Added 0.24%	52,866 $706,000
Q3 2018 Nov 13, 2018	SELL	$12.27 - $15.65 $136,614 - $174,247	-11,134 Reduced 17.43%	52,741 $739,000

Q2 2018 Aug 10, 2018	BUY	$15.3 - $19.69 $32,206 - $41,447	2,105 Added 3.41%	63,875 $1 Million
Q1 2018 May 14, 2018	BUY	$14.59 - $25.5 $161,088 - $281,545	11,041 Added 21.76%	61,770 $1.02 Million
Q4 2017 Feb 14, 2018	BUY	$15.77 - $20.72 $27,581 - $36,239	1,749 Added 3.57%	50,729 $916,000
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $602,454 - $945,314	48,980	48,980 $945,000

469

80.2M

596K

710K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $8.09B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.